Prudential Financial
CRVS icon

Prudential Financial’s Corvus Pharmaceuticals CRVS Stock Holding History

Prudential Financial’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Buy
+11,675
New +$186K ﹤0.01% 2166
2019
Q2 		– Sell
-14,939
Closed -$60K – 2460
2019
Q1 		$60K Sell
14,939
-6,606
-31% -$27.9K ﹤0.01% 2397
2018
Q4 		$79K Buy
21,545
+2,805
+15% +$19.1K ﹤0.01% 2318
2018
Q3 		$161K Sell
18,740
-200
-1% -$2K ﹤0.01% 2356
2018
Q2 		$208K Buy
+18,940
New +$211K ﹤0.01% 2335

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prudential Financial's CRVS Position: Q1 2026 in Review

Prudential Financial opened a new position in Corvus Pharmaceuticals (CRVS) in Q1 2026: 11,675 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #2166 among its holdings. This is a return to the name: Prudential Financial previously reported a position in CRVS as recently as Q1 2019.

Prudential Financial first reported a position in CRVS in Q2 2018 and has held it in 5 quarters since. The position peaked at $208K in Q2 2018. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • Prudential Financial held 11,675 shares of Corvus Pharmaceuticals worth $171K as of Q1 2026.
  • Corvus Pharmaceuticals was a new Prudential Financial position in Q1 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2166 holding.
  • Prudential Financial first reported a position in Corvus Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
  • Prudential Financial's Corvus Pharmaceuticals position peaked at $208K in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.